Flores, Baby Boy .
HRN: 24-32-42 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/10/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/10/2024
03/17/2024
IV
50 Mg
Q24
Thickly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes